Cargando…
Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis
INTRODUCTION: GlycA is a novel inflammatory biomarker measured using nuclear magnetic resonance (NMR). Its NMR signal primarily represents glycosylated acute phase proteins. GlycA was associated with inflammation and development of cardiovascular disease in initially healthy women. We hypothesized t...
Autores principales: | Ormseth, Michelle J., Chung, Cecilia P., Oeser, Annette M., Connelly, Margery A., Sokka, Tuulikki, Raggi, Paolo, Solus, Joseph F., Otvos, James D., Stein, C. Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445500/ https://www.ncbi.nlm.nih.gov/pubmed/25956924 http://dx.doi.org/10.1186/s13075-015-0646-x |
Ejemplares similares
-
GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
por: Connelly, Margery A., et al.
Publicado: (2017) -
Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis
por: Chung, Cecilia P, et al.
Publicado: (2006) -
A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
por: Bartlett, David B., et al.
Publicado: (2016) -
GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
por: Riggs, Kayla A., et al.
Publicado: (2022) -
GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function
por: Gruppen, Eke G., et al.
Publicado: (2015)